Ophthalmology News and Research

RSS

Ophthalmology is the specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology and diseases that may affect the eye. Historically, the science of ophthalmology encompassed all aspects of visual function, both in health and in illness. Additionally, ophthalmology also includes animal eyes as ocular function and optic diseases are similar among humans and animals.

Mount Sinai researchers use unbiased AI-based method to study the causes of cognitive impairment

Mount Sinai researchers have used novel artificial intelligence methods to examine structural and cellular features of human brain tissues to help determine the causes of Alzheimer's disease and other related disorders.

21 Sep 2022

Duke University Hospital selected as Center of Excellence for treating cerebral cavernous malformations

Duke University Hospital has been selected as a Center of Excellence for the treatment of brain abnormalities called cerebral cavernous malformations (CCM) in both adults and children.

19 Sep 2022

Private equity sees the billions in eye care as firms target high-profit procedures

Christina Green hoped cataract surgery would clear up her cloudy vision, which had worsened after she took a drug to fight her breast cancer.

19 Sep 2022

Father of modern corneal science honored with the 2022 António Champalimaud Vision Award

Claes H. Dohlman, MD, PhD, whose pioneering research at Mass Eye and Ear and in the Department of Ophthalmology at Harvard Medical School (HMS) has forever changed the way conditions of the cornea are understood and treated, has been presented with the 2022 António Champalimaud Vision Award for his vast contributions to vision research.

15 Sep 2022

Winners of the 2022 CURE-19 Research Pilot Grants announced

The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai and NYC Health + Hospitals have announced the 2022 awardees of the CURE-19 Research Pilot Grants, an initiative to support collaborative, interdisciplinary COVID-19 research that will address both the pandemic and root causes of health disparities in New York City.

14 Sep 2022

Research could lead to a new therapeutic option for patients with bladder cancer

Mount Sinai researchers have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the immune system.

12 Sep 2022

Low-dose ketamine is safe and effective to treat children with ADNP syndrome, study suggests

Results of a small, but unique research study, led by researchers from the Seaver Autism Center for Research and Treatment at Mount Sinai and published online in Human Genetics and Genomic Advances, suggest that low-dose ketamine is generally safe, well-tolerated and effective to treat clinical symptoms in children diagnosed with ADNP syndrome (also known as Helsmoortel-VanDerAa syndrome), a rare neurodevelopmental disorder caused by mutations in the activity dependent neuroprotective protein (ADNP) gene.

6 Sep 2022

Private equity ownership of physician practices may impose measures to squeeze out more profits, research says

New research reveals private equity firms that acquire physician-owned medical practices appear to be imposing measures to squeeze out more profits.

2 Sep 2022

Study shows encouraging therapeutic options for patients with relapsed multiple myeloma

Mount Sinai researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line treatment with bispecific antibodies fails.

1 Sep 2022

Individuals with early-onset diabetes, hypertension more likely to develop primary open-angle glaucoma

The earlier individuals develop Type 2 diabetes or hypertension in life, the earlier they are likely to develop primary open-angle glaucoma (POAG), the leading cause of irreversible blindness worldwide, researchers from UT Southwestern reported in a recent study.

29 Aug 2022

Novel method for accurate diagnosis and treatment of uveitis

An estimated five to ten percent of blindness worldwide is caused by the rare inflammatory eye disease uveitis. Posterior uveitis in particular is often associated with severe disease progression and the need for immunosuppressive therapy.

29 Aug 2022

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

A large-scale international study led by Mount Sinai has yielded the first risk score that can help predict mortality for patients with atrial fibrillation (AFib) who have undergone a successful transcatheter aortic valve replacement (TAVR) and discharged home.

29 Aug 2022

More than 50 new surgical hubs will open for tacking the Covid backlogs

Over 50 new surgical hubs will open across the country to help bust the Covid backlogs and offer hundreds of thousands more patients quicker access to vital procedures, the Health and Social Care Secretary Steve Barclay has announced today.

25 Aug 2022

Caffeine metabolite could become a valuable treatment for myopia in children

A metabolite of caffeine, known as 7-MX, may slow the progression of short-sightedness, also known as myopia, in children, suggests observational research published online in the British Journal of Ophthalmology.

23 Aug 2022

Clinical trial offers the best treatment option for patients with sight loss as a result of diabetes

A new clinical trial researching treatment for patients with sight loss as a result of diabetes has shown a type of laser treatment to be both cost effective and non-invasive, offering the best option for patients and healthcare providers.

23 Aug 2022

Cornea implant made of collagen from pig’s skin restores vision

In this interview, News-Medical speaks to Professors Neil Lagali and Mehrdad Rafat about their latest research, which detailed a bioengineered corneal tissue for minimally invasive vision restoration in advanced keratoconus in two clinical cohorts.

23 Aug 2022

Johns Hopkins Medicine researchers challenge the prevailing belief on how nasal cells process scent

Johns Hopkins Medicine researchers say they have evidence to potentially overturn a prevailing belief in a type of important signaling within cells.

18 Aug 2022

Genetic variant associated with Alzheimer's disease plays a role in protecting against glaucoma

New research led by scientists at Mass Eye and Ear and Brigham and Women's Hospital, member hospitals of Mass General Brigham, reveals the role that a genetic variant associated with Alzheimer's disease, APOE4, plays in protecting against glaucoma.

16 Aug 2022

Financial incentives from pharma companies can influence how vision care practitioners prescribe branded eyedrops

In a lookback study of prescribing patterns among thousands of American ophthalmologists and optometrists, Johns Hopkins Medicine researchers concluded that eye doctors who receive even small financial incentives from pharmaceutical companies, such as free food, sponsored travel to attend meetings or consulting fees, are up to twice as likely to prescribe the companies' brand name eyedrops for glaucoma instead of cheaper generic versions.

15 Aug 2022

Mount Sinai and Regeneron Genetics Center launch a new human genome sequencing research project

Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing research project called the Mount Sinai Million Health Discoveries Program with the Regeneron Genetics Center (RGC), part of the industry-leading, New York-based biotechnology company Regeneron.

12 Aug 2022

Ophthalmology News and Research

Further Reading

Mount Sinai researchers use unbiased AI-based method to study the causes of cognitive impairment

Duke University Hospital selected as Center of Excellence for treating cerebral cavernous malformations

Private equity sees the billions in eye care as firms target high-profit procedures

Father of modern corneal science honored with the 2022 António Champalimaud Vision Award

Winners of the 2022 CURE-19 Research Pilot Grants announced

Research could lead to a new therapeutic option for patients with bladder cancer

Low-dose ketamine is safe and effective to treat children with ADNP syndrome, study suggests

Private equity ownership of physician practices may impose measures to squeeze out more profits, research says

Study shows encouraging therapeutic options for patients with relapsed multiple myeloma

Individuals with early-onset diabetes, hypertension more likely to develop primary open-angle glaucoma

Novel method for accurate diagnosis and treatment of uveitis

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

More than 50 new surgical hubs will open for tacking the Covid backlogs

Caffeine metabolite could become a valuable treatment for myopia in children

Clinical trial offers the best treatment option for patients with sight loss as a result of diabetes

Cornea implant made of collagen from pig’s skin restores vision

Johns Hopkins Medicine researchers challenge the prevailing belief on how nasal cells process scent

Genetic variant associated with Alzheimer's disease plays a role in protecting against glaucoma

Financial incentives from pharma companies can influence how vision care practitioners prescribe branded eyedrops

Mount Sinai and Regeneron Genetics Center launch a new human genome sequencing research project

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News